Furthermore, these double mutant mice developed not only highly proliferative BL but also less proliferative types of lymphomas as observed in human patients where c-myc deregulation frequently occurs in pathologies such as MCL and plasmablastic cell lymphomas (PCL). Here, MYC is linked to lymphoma.